The not-so-simple HDL story: A new era for quantifying HDL and cardiovascular risk?

Nature Medicine

Volumn 18, Issue 9, 2012, Pages 1346-1347

  Heinecke, Jay W ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; APOLIPOPROTEIN A1;

ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL TRANSPORT; PRIORITY JOURNAL; PROTEIN FUNCTION; SHORT SURVEY; ARTICLE; ATHEROSCLEROSIS; BIOLOGICAL MODEL; BLOOD; HUMAN; MACROPHAGE; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

APOLIPOPROTEIN A-I; ATHEROSCLEROSIS; BIOLOGICAL TRANSPORT; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; HUMANS; LIPOPROTEINS, HDL; MACROPHAGES; MODELS, BIOLOGICAL;

EID: 84868641847     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2930     Document Type: Short Survey

References (10)

1. Rader, D.R. & Tall, A.R. Nat. Med. 18, 1344-1346 (2012).
2. Tall, A.R., Yvan-Charvet, L., Terasaka, N., Pagler, T. & Wang, N. Cell Metab. 7, 365-375 (2008).
3. Bérard, A.M. et al. Nat. Med. 3, 744-749 (1997).
4. Trigatti, B. et al. Proc. Natl. Acad. Sci. USA 96, 9322-9327 (1999).
5. de la Llera-Moya, M. et al. Arterioscler. Thromb. Vasc. Biol. 30, 796-801 (2010).
6. Khera, A.V. et al. N. Engl. J. Med. 364, 127-135 (2011).
7. Rosenson, R.S. et al. Clin. Chem. 57, 392-410 (2001).
8. Vaisar, T. et al. J. Clin. Invest. 117, 746-756 (2007).
9. Mackey, R.H. et al. J. Am. Coll. Cardiol. 60, 508-516 (2012).
10. Green, P.S. et al. Circulation 118, 1259-1267 (2008).